Skip to main navigation Skip to search Skip to main content

All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)

  • E. J. Lawitz
  • , M. Rodriguez-Torres
  • , J. Denning
  • , A. Mathias
  • , H. Mo
  • , B. Gao
  • , M. T. Cornpropst
  • , M. M. Berrey
  • , W. T. Symonds

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'All-oral therapy with nucleotide inhibitors sofosbuvir and GS-0938 for 14 days in treatment-naive genotype 1 hepatitis C (NUCLEAR)'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science